Cessation [acty]
Hormone replacement therapy [topp]
Plasma [bdsu]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Fibrinogen [aapp, bacs, phsu]
Objective [inpr]
Hormone replacement therapy [topp]
Documented [hlca]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
fibrinogen levels [lbpr]
Plasma [bdsu]
postmenopausal [tmco]
Women [popg]
Wash [acty]
Out [spco]
Protocol [inpr]
Study [mnob]
stopping [inch, phsu]
Hormone replacement therapy [topp]
Estrogen [horm, phsu, strd]
Alone [qnco]
Combination [qlco]
Estrogen [horm, phsu, strd]
Progestin [horm, phsu, strd]
effects [qlco]
Marker [clna]
Haemostasis [ortf]
Study Design [resa]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Hormone replacement therapy [topp]
Oestradiol valerate [horm, phsu, strd]
Oestradiol valerate [horm, phsu, strd]
Levonorgestrel [horm, phsu, strd]
Study [mnob]
Hormone replacement therapy [topp]
weeks [tmco]
Cessation [acty]
treatment [ftcn]
Wash [acty]
Out [spco]
weeks [tmco]
therapy [ftcn]
Estrogen [horm, phsu, strd]
Group [idcn]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Increased [qnco]
Wash [acty]
Out [spco]
P NOS [aapp, imft]
Decreased [qnco]
Reintroduction [topp]
therapy [ftcn]
P NOS [aapp, imft]
Combined therapy [topp]
Group [idcn]
trend [tmco]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
therapy [ftcn]
Discontinued [fndg]
P NOS [aapp, imft]
Decreased [qnco]
Reintroduction [topp]
Hormone replacement therapy [topp]
P NOS [aapp, imft]
Fibrinogen [aapp, bacs, phsu]
Initially [tmco]
Estrogen [horm, phsu, strd]
Group [idcn]
Compared [acty]
Combined therapy [topp]
Group [idcn]
P NOS [aapp, imft]
0.014" [qnco]
Wash [acty]
Out [spco]
Wash [acty]
Out [spco]
Study [mnob]
Cessation [acty]
Hormone replacement therapy [topp]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
APPEAR [qlco]
Adverse Effect [fndg]
Fibrinogen [aapp, bacs, phsu]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
